Patent · US Active

GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis

US8968748B2 · kind B2 · utility

37Cited by
10References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 21, 2011
Grant dateMar 3, 2015
Priority date
Expiry dateOct 21, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/825
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention generally provides methods and compositions for eliciting an immune response against Neisseria spp. bacteria in a subject, particularly against a Neisseria meningitidis serogroup B strain.check for moving around

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.